True Link Financial Advisors, LLC Johnson & Johnson Transaction History

True Link Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$155.75 - $174.48 $57,004 - $63,859	366 Added 14.52%	2,886 $449,000
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $11,941 - $13,206	71 Added 2.9%	2,520 $447,000
Q4 2021 Feb 01, 2022	BUY	$155.93 - $173.01 $36,643 - $40,657	235 Added 10.61%	2,449 $419,000
Q3 2021 Oct 29, 2021	BUY	$161.5 - $179.47 $80,750 - $89,735	500 Added 29.17%	2,214 $358,000
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $41,788 - $46,541	-273 Reduced 13.74%	1,714 $282,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $272,437 - $312,714	1,987 New	1,987 $313,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.